New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti‐Tumor Activity Against Ewing SarcomaCaroline de Bem Gentz, Saulo Fernandes de Andrade|Archiv der Pharmazie|2026Cited by 0